Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SZSE: 002940)
Health Care · Pharmaceuticals · CN
CN¥22.96
+0.53% today · -38.6% 1Y
Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SZSE: 002940) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $671.26M and employs 1,236 people.
Over the last twelve months the share price has lost 38.6%, trading between 22.22 and 48.90.
Tweenvest scores Zhejiang AngLiKang Pharmaceutical CO.,LTD. across four factors: quality 80/100, value 39/100, growth 21/100. Its strongest factor is quality.
002940 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $671.26M
- Revenue (TTM)
- $195.43M
- P/E
- 40.96
- EPS
- 0.56
- Dividend yield
- —
- Beta (5Y)
- 0.70
- 52-week high
- CN¥48.90
- 52-week low
- CN¥22.22
- Avg volume (3M)
- —
- Shares outstanding
- 196.11M
- Employees
- 1,236
- Next earnings
- —
About Zhejiang AngLiKang Pharmaceutical CO.,LTD.
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on the manufacturing and distribution of various pharmaceutical goods. Their operations span the production and sale of active pharmaceutical ingredients (APIs), finished drug formulations, and empty capsules for medical use. The company's existing product line encompasses treatments for a variety of conditions, including anti-infective agents, antihypertensives for blood pressure management, medications for digestive system health, and respiratory preparations. Beyond its current offerings, AngLiKang is also deeply involved in drug research and development. Their R&D efforts are concentrated on creating new therapies, with a particular emphasis on oral cephalosporin antibiotics, as well as treatments for cardiovascular, renal (kidney), and central nervous system diseases. The company was established in 2001 and maintains its headquarters in Shengzhou, China.
- ISIN
- CNE100003GC2
- Founded
- 2001
- Listed since
- Oct 23, 2018
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Wave Life Sciences, Inc.NasdaqGM: WVE | $683.76M | $3.47 | -1.98% |
| Hunan Hansen Pharmaceutical Co., Ltd.SZSE: 002412 | $680.41M | CN¥9.07 | -0.33% |
| Hunan Fangsheng Pharmaceutical Co., Ltd.SHSE: 603998 | $678.15M | CN¥10.36 | +0.68% |
| Sinotherapeutics Inc.SHSE: 688247 | $675.40M | CN¥10.09 | +2.13% |
| PT Tempo Scan Pacific TbkIDX: TSPC | $665.25M | Rp2,640.00 | -0.38% |
| Lionco Pharmaceutical Group Co.,Ltd.SHSE: 603669 | $663.92M | CN¥6.33 | +7.29% |
| Tianjin Lisheng Pharmaceutical Co.,Ltd.SZSE: 002393 | $646.77M | CN¥14.08 | +1.88% |
| Senores Pharmaceuticals LimitedNSEI: SENORES | $645.55M | Rs1,349.60 | -0.41% |
Figures last refreshed Oct 4, 2026.